Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,019 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.
Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S, Nakano N, Ikeda Y, Sasaki T, Nishioka K, Hara M, Taguchi H, Kimura Y, Kato Y, Asaoku H, Kumagai S, Kodama F, Nakahara H, Hagihara K, Yoshizaki K, Kishimoto T. Nishimoto N, et al. Among authors: kishimoto t. Blood. 2005 Oct 15;106(8):2627-32. doi: 10.1182/blood-2004-12-4602. Epub 2005 Jul 5. Blood. 2005. PMID: 15998837 Free article. Clinical Trial.
Interleukin-6: discovery of a pleiotropic cytokine.
Kishimoto T. Kishimoto T. Arthritis Res Ther. 2006;8 Suppl 2(Suppl 2):S2. doi: 10.1186/ar1916. Epub 2006 Jul 28. Arthritis Res Ther. 2006. PMID: 16899106 Free PMC article. Review.
Interleukin 6: from bench to bedside.
Nishimoto N, Kishimoto T. Nishimoto N, et al. Among authors: kishimoto t. Nat Clin Pract Rheumatol. 2006 Nov;2(11):619-26. doi: 10.1038/ncprheum0338. Nat Clin Pract Rheumatol. 2006. PMID: 17075601 Review.
Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy.
Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J, Kishimoto T. Nishimoto N, et al. Among authors: kishimoto t. Mod Rheumatol. 2009;19(1):12-9. doi: 10.1007/s10165-008-0125-1. Epub 2008 Nov 1. Mod Rheumatol. 2009. PMID: 18979150 Free PMC article. Clinical Trial.
Therapeutic targeting of the interleukin-6 receptor.
Tanaka T, Narazaki M, Kishimoto T. Tanaka T, et al. Among authors: kishimoto t. Annu Rev Pharmacol Toxicol. 2012;52:199-219. doi: 10.1146/annurev-pharmtox-010611-134715. Epub 2011 Sep 9. Annu Rev Pharmacol Toxicol. 2012. PMID: 21910626 Review.
3,019 results